Ribosomal protein L35a pseudogene 24 (RPL35AP24)

Ribosomal protein L35a pseudogene 24 (RPL35AP24) is classified as a processed pseudogene in the human genome, related in sequence to the functional ribosomal protein L35a gene (RPL35A)[1][5][6]. Pseudogenes are DNA sequences that resemble known genes but are typically nonfunctional due to accumulated mutations preventing them from encoding active proteins[4]. RPL35AP24 does not produce a functional ribosomal protein and is not involved in ribosome assembly or protein synthesis. There is no evidence that this pseudogene functions as a therapeutic target, receptor, enzyme, or any other common drug-targeted molecular entity. No clinical, pharmacological, or biomarker significance has been reported for RPL35AP24 in the current biomedical literature or gene annotation resources[1][5][6]. Note: Pseudogenes similar to RPL35AP24 can sometimes exert regulatory effects through RNA-mediated mechanisms or act as decoys for microRNAs, but such functions have not been established for RPL35AP24 specifically. There is a broader scientific interest in pseudogenes, as some play roles in cancer and development, but these findings do not apply to this specific entity[4]. No approved drugs, mechanisms of action, or disease linkages have been identified for RPL35AP24, and it is not a therapeutic target by any known definition[1][2][5][6].

Other names

RPL35A_12_1042[5]ribosomal protein L35a pseudogene 24